SEC Form 4 · accession 0001104659-26-083588
Liminatus Pharma, Inc. · LIMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Chris Kim
Officer — Chief Executive Officer · Director · 10% Owner
Valetudo Therapeutics LLC
10% Owner
Period of report
Jul 2, 2026
Accepted (ET)
Jul 14, 2026 · 5:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001971387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1,F2 | Jul 2, 2026 | J | 3,448,926 | — | A | 5,244,351 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock, par value $0.0001 per shareF1,F2 | — | holding | — | — | — | — | — | Common Stock, par value $0.0001 per share | 489,751,074 | 48,975 | D |
Explanation of responses
- F1Consists of 5,244,351 shares of common stock held of record by Valetudo Therapeutics LLC ("Valetudo"). On July 2, 2026, Valetudo received 3,448,926 shares of common stock and 48,975.10742 shares of the registrant's newly designated Series A Non-Voting Convertible Preferred Stock ("Series A Preferred Stock") as consideration paid to former members of InnocsAI LLC ("InnocsAI") in connection with the registrant's acquisition of InnocsAI. Each share of Series A Preferred Stock will be convertible into 10,000 shares of common stock at an issue price of $0.20 per share, which conversion is contingent upon prior stockholder approval of the issuance of the underlying common shares to the extent required under applicable Nasdaq Stock Market LLC listing rules.
- F2The Series A Preferred Stock has no expiration date. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo is 2251 Stern Goodman Street, Suite E, Fullerton, California 92833. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.